Abstract
Despite the widespread use of calcium-channel blockers, there are lingering concerns about their putative association with increased cardiovascular risk. To address this controversial issue, investigators used data from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial, a prospective, randomized, blinded study that …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
